The 27 references in paper K. Kryshen L., A. Katelnikova E., A. Muzhikyan A., M. Маkarova N., V. Makarov G., К. Крышень Л., А. Кательникова Е., А. Мужикян А., М. Макарова Н., В. Макаров Г. (2018) “РЕГУЛЯТОРНЫЕ И МЕТОДИЧЕСКИЕ АСПЕКТЫ ИЗУЧЕНИЯ АЛЛЕРГИЗИРУЮЩИХ СВОЙСТВ НОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ НА ЭТАПЕ ДОКЛИНИЧЕСКИХ ИССЛЕДОВАНИЙ // REGULATORY AND METHODOLOGICAL ASPECTS OF STUDYING ALLERGENIC PROPERTIES OF NEW MEDICINES AT THE PRECLINICAL STAGE” / spz:neicon:vedomostincesmp:y:2018:i:1:p:44-55

1
Руководство по проведению доклинических исследований лекарственных средств. Ч. 1. М: Гриф и К; 2012. [Guidance on preclinical evaluation of medicines. Part 1. Moscow: Grif i K; 2012 (In Russ.)]
(check this in PDF content)
2
Руководство по экспертизе лекарственных средств. Т. 1. М.: Гриф и К; 2013. [Guidance on evaluation of medicines. V. I. Moscow: Grif i K; 2013 (In Russ.)]
(check this in PDF content)
3
ICH M3(R2) Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals M3(R2); 2009.
(check this in PDF content)
4
ГОСТ Р 56701-2015. Лекарственные средства для медицинского применения. Руководство по планированию доклинических исследований безопасности с целью последующего проведения клинических исследований и регистрации лекарственных средств. М.: Стандартинформ; 2016. [State Standard R 56701-2015. Medicinal products for medical use. Guidelines for the planning of preclinical safety studies for the purpose of subsequent clinical trials and registration of drugs. Moscow: Standartinform; 2016 (In Russ.)]
(check this in PDF content)
5
Сепиашвили РИ, Славянская ТА. Белая книга WAO по аллергии 2011–2012: резюме. М.: Медицина-Здоровье; 2011. [Sepiashvili RI, Slavyanskaya TA. WAO White book of Allergy 2011–2012: Resume. Moscow: Meditsina-Zdorovie; 2011 (In Russ.)]
(check this in PDF content)
6
Елисеева ТИ, Балаболкин ИИ. Аллергические реакции на лекарственные средства: современные представления (обзор). Современные технологии в медицине 2016; 8(1): 159–72. [Eliseeva TI, Balabolkin II. Allergic reactions to medicines: modern views (review). Modern Technologies in Medicine 2016; 8(1): 159–72 (In Russ.)]
(check this in PDF content)
7
Колодийчук ЕВ, Грудина ЕВ, Малашенкова ТЕ. Лекарственная аллергия. Медицинский вестник Северного Кавказа 2007; (2): 70–5. [Kolodijchuk EV, Grudina EV, Malashenkova TE. Drug Allergy. The Medical Bulletin of the North Caucasus 2007; (2): 70–5 (In Russ.)]
(check this in PDF content)
8
Хаитов РМ, Ильина НИ. Аллергология и иммунология: национальное руководство. М.: ГЭОТАР-Медиа; 2009. [Haitov RM, Ilyina NI. Allergology and Immunology: National Guideline. Moscow: GEOTAR-Media; 2009 (In Russ.)]
(check this in PDF content)
9
Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK. Immunological Principles of Adverse Drug Reactions: the Initiation and Propagation of Immune Responses Elicited by Drug Treatment. Drug Saf 2000; 23(6): 483–507.
(check this in PDF content)
10
Gell PGH, Coombs RRA. Clinical Aspects of Immunology. Oxford– Edinburg; 1975.
(check this in PDF content)
11
Schnyder B, Brockow K. Pathogenesis of Drug Allergy — Current Concepts and Recent Insights. Clin Exp Allergy 2015; 45(9): 1376–83.
(check this in PDF content)
12
Landsteiner K, Jacobs J. Studies on the Sensitization of Animals with Simple Chemical Compounds. J Exp Med 1935; 61(5): 643–56.
(check this in PDF content)
13
Bugelski PJ. Genetic Aspects of Immune-Mediated Adverse Drug Effects. Nature 2005; (4): 59–69.
(check this in PDF content)
14
Park BK, Coleman JW, Kitteringham NR. Drug Disposition and Drug Hypersensitivity. Biochem Pharmacol. 1987; 36(5): 581–90.
(check this in PDF content)
15
Ratajczak HV. Drug-Induced Hypersensitivity. Toxicol Rev. 2004; 23(4): 265–80.
(check this in PDF content)
16
Новиков ПД, Новиков ДК. Механизмы аллергии на лекарствагаптены. Иммунопатология, аллергология, инфектология 2000; (4): 48–64. [Novikov PD, Novikov DK. Mechanisms of allergy to drugs-haptens. Immunopathology, Allergology, Infectology 2000; (4): 48–64 (In Russ.)]
(check this in PDF content)
17
Pichler WJ. Delayed Drug Hypersensitivity Reactions. Ann Intern Med. 2003; 139(8): 683–93.
(check this in PDF content)
18
ICH S8 Immunotoxicity Studies for Human Pharmaceuticals. U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (СBER); 2006.
(check this in PDF content)
19
Immunotoxicology Evaluation of Investigational New Drugs. U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research (CDER);
(check this in PDF content)
20
2. 20. Межгосударственный стандарт ГОСТ 32375-2013. Методы испытания по воздействию химической продукции на организм человека. Испытания по оценке кожной сенсибилизации. М.: Стандартинформ; 2014. [Interstate Standard GOST 32375-2013. Test methods for the effects of chemical products on the human body. Tests for the evaluation of skin sensitization. Moscow: Standartinform; 2014 (In Russ.)]
(check this in PDF content)
21
Ацапкина АA, Крышень КЛ, Касторнова АЕ, Макарова МН, Макаров ВГ. Иммунологический статус лабораторных животных при моделировании состояний гиперчувствительности немедленного типа. Международный вестник ветеринарии 2014; (1): 91–9. [Atsapkina AА, Kryshen KL, Kastornova AE, Makarova MN, Makarov VG. Immunological status of laboratory animals in the modeling of immediate-type hypersensitivity. International Veterinary Journal 2014; (1): 91–9 (In Russ.)]
(check this in PDF content)
22
Weigle WO, Cochrane CG, Dixon FJ. Anaphylactogenic Properties of Soluble Antigen-Antibody Complexes in the Guinea Pig and Rabbit. J Immunol. 1960; 85: 469–77.
(check this in PDF content)
23
Овчинникова ЕA, Овчинникова ЛK. Спектр безопасности ванкомицина. Качественная клиническая практика 2004; (2): 36–48. [Ovchinnikova EA, Ovchinnikova LK. Safety profile of vancomycin. Qualitative Clinical Practice 2004; (2): 36–48 (In Russ.)]
(check this in PDF content)
24
Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, Diagnosis, and Treatment of Aspirin Intolerance. Ann Allergy Asthma Immunol. 2007; 99(1): 13–21.
(check this in PDF content)
25
Chazal I, Verdier F, Virat M, Descotes J. Prediction of Drug-Induced Immediate Hypersensitivity in Guinea Pigs. Toxicol In Vitro 1994; 8(5): 1045–7.
(check this in PDF content)
26
Choquet-Kastylevsky G, Descotes J. Value of Animal Models for Predicting Hypersensitivity Reactions to Medicinal Products. Toxicology 1998; 129(1): 27–35.
(check this in PDF content)
27
Weaver JL, Staten D, Swann J, Armstrong G, Bates M, Hastings KL. Detection of Systemic Hypersensitivity to Drugs Using Standard Guinea Pig Assays. Toxicology 2003; 193(3): 203–17. ОБ АВТОРАХ Акционерное общество «Научно-производственное объединение «ДОМ
(check this in PDF content)